Posted by: admin on: October 20, 2011
The ProPublica database attempts to provide transparency in a field where there can be a fine line between doctors who are too cozy with the drug industry, and those fulfilling a legitimate role as researchers and educators. -Team@CMHF
Posted by: admin on: October 13, 2011
by Daniel J. Carlat, MD Recently, the FDA has rejected another anti-obesity drug, Contrave, because of concerns that it might cause heart attacks in patients who take it for years. FDA’s excessive caution was motivated by its experience having been burned by the Fen-Phen fiasco. This was a weight loss drug widely prescribed in the […]
Posted by: admin on: October 7, 2011
The more clearly we physicians communicate, and less medical jargons we use the better will be our patients’ understanding of their ailments. The important topic of doctor-patient communication led a neurosurgeon Dr. Thomas Lansen, to make some suggestions, which has been paraphrased and amplified. It is important for both doctors and patients to understand each other’s points of view, as […]
Posted by: admin on: October 5, 2011
The sickest 5% of Americans account for over 40% of U.S. healthcare spending. The goal of disease management is to reduce costs and/or improve quality of life of patients afflicted with chronic diseases like congestive heart failure, cancer and chronic renal disease. Disease management is a system of coordinated health care interventions that emphasizes outpatient […]